Hummingbird Biosciences

Hummingbird Bioscience Announces HMBD-002 Trials in Progress Poster at ASCO Annual Meeting 2023
BioSpace
Tue, 05/30/23 - 09:47 am
Hummingbird Biosciences
HMBD-002
cliincal trials
ASCO 2023
triple-negative breast cancer
non-small cell lung cancer
Eyeing clinical proof-of-concept for HER3 drug, Amgen-partnered biotech scores $125M for precision antibodies
Endpoints
Tue, 05/18/21 - 11:28 pm
Singapore
Novo Holdings
precision antibodies
Hummingbird Biosciences
Funding News: Three Biopharmas Score a Combined $261 Million to Advance Pipelines
BioSpace
Tue, 05/18/21 - 11:21 pm
funding
Hummingbird Biosciences
eureKARE
microbiome
Interius BioTherapeutics
cell therapy
gene therapy